Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Draper

Showing results (141-150 of 163) with videos related to

Pageof 17
Sort By:
JAMIA Open|January 29, 2024
Design and evaluation of an electronic prospective medication order review system for medication orders in the inpatient settingPooja Ojha, Benjamin J Anderson, Evan W Draper, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|February 29, 2000
Treatment of postmenopausal women with osteoporosis or low bone density with raloxifene. Raloxifene Study GroupP J Meunier, E Vignot, P Garnero, et al.
Journal of Medicinal Chemistry|January 1, 1983
Novel 17 alpha-chloro-17 beta-sulfinyl steroids as specific inhibitors of sebaceous gland activity: potential antiacne agentsM J Green, R Tiberi, R W Draper, et al.
Plos Genetics|June 17, 2021
Rad21l1 cohesin subunit is dispensable for spermatogenesis but not oogenesis in zebrafishYana P Blokhina, Michelle A Frees, An Nguyen, et al.
The Journal of Allergy and Clinical Immunology|October 6, 2009
Novel relationship of serum cholesterol with asthma and wheeze in the United StatesMichael B Fessler, Mark W Massing, Brian Spruell, et al.
Archives of Internal Medicine|April 28, 2004
A comparison of the effects of raloxifene and conjugated equine estrogen on bone and lipids in healthy postmenopausal womenIan R Reid, Richard Eastell, Ignac Fogelman, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 29, 2010
Dyslipidemia induces opposing effects on intrapulmonary and extrapulmonary host defense through divergent TLR response phenotypesJennifer H Madenspacher, David W Draper, Kathleen A Smoak, et al.
Annals of the New York Academy of Sciences|June 12, 1995
Raloxifene is a tissue-selective agonist/antagonist that functions through the estrogen receptorR Fuchs-Young, A L Glasebrook, L L Short, et al.
Menopause (New York, N.Y.)|July 10, 2003
Prevention of osteoporosis and uterine effects in postmenopausal women taking raloxifene for 5 yearsElaine E Jolly, Nina H Bjarnason, Patrick Neven, et al.
Molecular Biology of the Cell|March 29, 2023
Electric field-guided collective motility initiation of large epidermal cell groupsYaohui Sun, Brian Reid, Yan Zhang, et al.
Pageof 17

Showing results (141-150 of 163) with videos related to

Sort By:
Pageof 17
JAMIA Open|January 29, 2024
Design and evaluation of an electronic prospective medication order review system for medication orders in the inpatient settingPooja Ojha, Benjamin J Anderson, Evan W Draper, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|February 29, 2000
Treatment of postmenopausal women with osteoporosis or low bone density with raloxifene. Raloxifene Study GroupP J Meunier, E Vignot, P Garnero, et al.
Journal of Medicinal Chemistry|January 1, 1983
Novel 17 alpha-chloro-17 beta-sulfinyl steroids as specific inhibitors of sebaceous gland activity: potential antiacne agentsM J Green, R Tiberi, R W Draper, et al.
Plos Genetics|June 17, 2021
Rad21l1 cohesin subunit is dispensable for spermatogenesis but not oogenesis in zebrafishYana P Blokhina, Michelle A Frees, An Nguyen, et al.
The Journal of Allergy and Clinical Immunology|October 6, 2009
Novel relationship of serum cholesterol with asthma and wheeze in the United StatesMichael B Fessler, Mark W Massing, Brian Spruell, et al.
Archives of Internal Medicine|April 28, 2004
A comparison of the effects of raloxifene and conjugated equine estrogen on bone and lipids in healthy postmenopausal womenIan R Reid, Richard Eastell, Ignac Fogelman, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 29, 2010
Dyslipidemia induces opposing effects on intrapulmonary and extrapulmonary host defense through divergent TLR response phenotypesJennifer H Madenspacher, David W Draper, Kathleen A Smoak, et al.
Annals of the New York Academy of Sciences|June 12, 1995
Raloxifene is a tissue-selective agonist/antagonist that functions through the estrogen receptorR Fuchs-Young, A L Glasebrook, L L Short, et al.
Menopause (New York, N.Y.)|July 10, 2003
Prevention of osteoporosis and uterine effects in postmenopausal women taking raloxifene for 5 yearsElaine E Jolly, Nina H Bjarnason, Patrick Neven, et al.
Molecular Biology of the Cell|March 29, 2023
Electric field-guided collective motility initiation of large epidermal cell groupsYaohui Sun, Brian Reid, Yan Zhang, et al.
Pageof 17